Abstract
Background Adverse pregnancy outcomes affect approximately 20% pregnant women, and their incidence is increasing.
Objective To investigate the effect of cardiovascular health during pregnancy on adverse pregnancy outcomes and the effect modification by psychological distress, social isolation, and income.
Study Design We analyzed data from 14,930 pregnant women in the Tohoku Medical Megabank Project Birth and Three-Generation Cohort Study. Cardiovascular health status during pregnancy was assessed using the eight components of Life’s Essential 8 as proposed by the American Heart Association, including diet, physical activity, nicotine exposure, sleep health, body mass index, blood lipids, blood glucose, and blood pressure. Adverse pregnancy outcomes were defined as composite outcomes of preeclampsia, gestational diabetes mellitus, preterm birth, and small for gestational age. Using logistic regression analyses, we examined the associations between cardiovascular health and adverse pregnancy outcomes, preeclampsia, gestational diabetes mellitus, preterm birth, small for gestational age, large for gestational age, low birth weight, and neonatal intensive care unit admission. Interactions with psychological distress, social isolation, and income were examined.
Results The numbers of participants with high, moderate, and low cardiovascular health status were 2,891 (19.4%), 11,498 (77.0%), and 541 (3.6%), respectively. Moderate and low cardiovascular health status were positively associated with adverse pregnancy outcomes (odds ratio and 95% confidence interval: 1.17 (10.04 to 1.32) and 2.64 (2.13 to 3.27), respectively). Low cardiovascular health status was also associated with a higher prevalence of preeclampsia, gestational diabetes mellitus, preterm birth, large for gestational age, and neonatal intensive care unit admission, and lower prevalence of small for gestational age. Among pregnant women with low cardiovascular health status, those who reported social isolation had a higher prevalence of adverse pregnancy outcomes than did those without social isolation (36.4% vs. 27.4%). However, this difference was attenuated for pregnant women with high cardiovascular health status (13.6% vs. 13.1%).
Conclusions Cardiovascular health status assessed using Life’s Essential 8 may be useful for assessing the risk of adverse pregnancy outcomes. Socially isolated pregnant women are more vulnerable to the effects of low cardiovascular health status; thus, they should be prioritized for access to primary care, lifestyle education, and appropriate pharmacotherapy.
Tweetable Statement Cardiovascular health impacts pregnancy outcomes. Social isolation exacerbates these risks. Improving cardiovascular health, particularly in socially isolated women, is crucial to reducing health disparities.
Why was this study conducted?
Adverse pregnancy outcomes affect approximately 20% pregnant women and are increasing. We hypothesized that preventive strategies employed for cardiovascular diseases can be applied to adverse pregnancy outcomes.
What are the key findings?
Pregnant women with low cardiovascular health status had an increased risk of adverse pregnancy outcomes, preeclampsia, gestational diabetes mellitus, preterm birth, large for gestational age, and neonatal intensive care unit admission.
In addition, socially isolated pregnant women were more affected by low cardiovascular health status and faced a greater risk of adverse pregnancy outcomes.
What does this study add to what is already known?
Improving cardiovascular health during pregnancy, especially for socially isolated women, is necessary to minimize health disparities.
Competing Interest Statement
KM is an employee of the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Funding Statement
This work was supported by the Japan Agency for Medical Research and Development (AMED), Japan (Grant Nos. JP19gk0110039, JP17km0105001, JP21tm0124005, and JP21tm0424601), Japanese Society for the Promotion of Science KAKENHI (Grant No. JP21K10438), and The Seiichi Imai Memorial Foundation (2023).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Ethics Committee of the Tohoku Medical Megabank Organization (2013-1-103-1)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Individual data are available upon request after the approval of the Ethical Committee and the Materials and Information Distribution Review Committee of Tohoku Medical Megabank Organization.
